Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Yohhei Hamada

Datos Biográficos

ID9065408
NOMBREYohhei Hamada
NOMBRESYohhei
APELLIDOHamada
FIRMAHAMADA Y
AFILIACIONESUniversity College London
ORCID0000-0002-9845-4267
VERIFICADOSí
TOTAL DE OBRAS6
TOTAL DE CITAS0
TOTAL COMO AUTOR6
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2022
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0
  • Policies, practices, opportunities and challenges for tuberculosis screening

    Open Access•Liana Macpherson, Cecily Miller et al.•ARTICLE•BMJ Global Health•2025

    INTRODUCTION: There are limited published data on how countries carry out screening for tuberculosis (TB) disease and what the perceived challenges are for implementing screening from a country perspective. Understanding these factors are important to enable better planning and support for the roll-out of appropriate screening interventions. METHODS: We conducted a cross-sectional survey of national TB programmes from countries reporting >1000 TB…

  • Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma rel…

    Open Access•Lara Goscé, Kasim Allel et al.•ARTICLE•PLOS Global Public Health•2024

    The Purified Protein Derivative tuberculin skin tests (TST) and blood-based Mycobacterium tuberculosis (M . tb) specific interferon-gamma release assays (IGRA) are the currently used tests for identifying individuals with TB infection for preventive treatment. However, challenges around access and implementation have limited their use. Novel M . tb specific skin tests (TBST) such as Diaskintest, ESAT6-CFP10 (C-TST), C-Tb (also known as Cy-Tb), an…

  • Tobacco smoking clusters in households affected by tuberculosis in an individual participant data meta-analysis of national tuberculosis prevalence surveys

    Open Access•Yohhei Hamada, Matteo Quartagno et al.•ARTICLE•PLOS Global Public Health•2024

    Tuberculosis (TB) and non-communicable diseases (NCD) share predisposing risk factors. TB-associated NCD might cluster within households affected with TB requiring shared prevention and care strategies. We conducted an individual participant data meta-analysis of national TB prevalence surveys to determine whether NCD cluster in members of households with TB. We identified eligible surveys that reported at least one NCD or NCD risk factor through…

  • Optimizing the cascade of prevention to protect people from tuberculosis

    Open Access•Alberto Matteelli, Gavin Churchyard et al.•ARTICLE•PLOS Global Public Health•2024

    The provision of tuberculosis preventive treatment is one of the critical interventions to reduce tuberculosis incidence and ultimately eliminate the disease, yet we still miss appropriate tools for an impactful intervention and treatment coverage remains low. We used recent data, epidemiological estimates, and research findings to analyze the challenges of each step of the cascade of tuberculosis prevention that currently delay the strategy impl…

  • Economic evaluation of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection

    Open Access•Lara Goscé, Kasim Allel et al.•ARTICLE•PLOS Global Public Health•2023

    Evidence on the economic impact of novel skin tests for tuberculosis infection (TBST) is scarce and limited by study quality. We used estimates on the cost-effectiveness of the use of TBST compared to current tuberculosis infection (TBI) tests to assess whether TBST are affordable and feasible to implement under different country contexts. A Markov model parametrised to Brazil, South Africa and the UK was developed to compare the cost-effectivene…

  • Seroprevalence of Sars-CoV-2 in four states of Nigeria in October 2020

    Open Access•Rosemary Audu, Kristen A Stafford et al.•ARTICLE•PLOS Global Public Health•2022

    The observed epidemiology of SARS-CoV-2 in sub-Saharan Africa has varied greatly from that in Europe and the United States, with much lower reported incidence. Population-based studies are needed to estimate true cumulative incidence of SARS-CoV-2 to inform public health interventions. This study estimated SARS-CoV-2 seroprevalence in four selected states in Nigeria in October 2020. We implemented a two-stage cluster sample household survey in fo…

Sin obras prominentes en esta página.

  • Seroprevalence of Sars-CoV-2 in four states of Nigeria in October 2020

    Open Access•Rosemary Audu, Kristen A Stafford et al.•ARTICLE•PLOS Global Public Health•2022

    The observed epidemiology of SARS-CoV-2 in sub-Saharan Africa has varied greatly from that in Europe and the United States, with much lower reported incidence. Population-based studies are needed to estimate true cumulative incidence of SARS-CoV-2 to inform public health interventions. This study estimated SARS-CoV-2 seroprevalence in four selected states in Nigeria in October 2020. We implemented a two-stage cluster sample household survey in fo…

  • Economic evaluation of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection

    Open Access•Lara Goscé, Kasim Allel et al.•ARTICLE•PLOS Global Public Health•2023

    Evidence on the economic impact of novel skin tests for tuberculosis infection (TBST) is scarce and limited by study quality. We used estimates on the cost-effectiveness of the use of TBST compared to current tuberculosis infection (TBI) tests to assess whether TBST are affordable and feasible to implement under different country contexts. A Markov model parametrised to Brazil, South Africa and the UK was developed to compare the cost-effectivene…

  • Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma rel…

    Open Access•Lara Goscé, Kasim Allel et al.•ARTICLE•PLOS Global Public Health•2024

    The Purified Protein Derivative tuberculin skin tests (TST) and blood-based Mycobacterium tuberculosis (M . tb) specific interferon-gamma release assays (IGRA) are the currently used tests for identifying individuals with TB infection for preventive treatment. However, challenges around access and implementation have limited their use. Novel M . tb specific skin tests (TBST) such as Diaskintest, ESAT6-CFP10 (C-TST), C-Tb (also known as Cy-Tb), an…

  • Tobacco smoking clusters in households affected by tuberculosis in an individual participant data meta-analysis of national tuberculosis prevalence surveys

    Open Access•Yohhei Hamada, Matteo Quartagno et al.•ARTICLE•PLOS Global Public Health•2024

    Tuberculosis (TB) and non-communicable diseases (NCD) share predisposing risk factors. TB-associated NCD might cluster within households affected with TB requiring shared prevention and care strategies. We conducted an individual participant data meta-analysis of national TB prevalence surveys to determine whether NCD cluster in members of households with TB. We identified eligible surveys that reported at least one NCD or NCD risk factor through…

  • Optimizing the cascade of prevention to protect people from tuberculosis

    Open Access•Alberto Matteelli, Gavin Churchyard et al.•ARTICLE•PLOS Global Public Health•2024

    The provision of tuberculosis preventive treatment is one of the critical interventions to reduce tuberculosis incidence and ultimately eliminate the disease, yet we still miss appropriate tools for an impactful intervention and treatment coverage remains low. We used recent data, epidemiological estimates, and research findings to analyze the challenges of each step of the cascade of tuberculosis prevention that currently delay the strategy impl…

  • Policies, practices, opportunities and challenges for tuberculosis screening

    Open Access•Liana Macpherson, Cecily Miller et al.•ARTICLE•BMJ Global Health•2025

    INTRODUCTION: There are limited published data on how countries carry out screening for tuberculosis (TB) disease and what the perceived challenges are for implementing screening from a country perspective. Understanding these factors are important to enable better planning and support for the roll-out of appropriate screening interventions. METHODS: We conducted a cross-sectional survey of national TB programmes from countries reporting >1000 TB…

Medicine (6 obras) · Tuberculosis (5 obras) · Tuberculosis Research and Epidemiology (5 obras) · Environmental health (4 obras) · Pathology (4 obras) · Immunology (3 obras) · Mycobacterium tuberculosis (3 obras) · Psychological intervention (3 obras) · Demography (2 obras) · Mycobacterium research and diagnosis (2 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae